Abstract

Hedgehog (HH) morphogen signalling, crucial for cell growth and tissue patterning in animals, is initiated by the binding of dually lipidated HH ligands to cell surface receptors. Hedgehog-Interacting Protein (HHIP), the only reported secreted inhibitor of Sonic Hedgehog (SHH) signalling, binds directly to SHH with high nanomolar affinity, sequestering SHH. Here, we report the structure of the HHIP N-terminal domain (HHIP-N) in complex with a glycosaminoglycan (GAG). HHIP-N displays a unique bipartite fold with a GAG-binding domain alongside a Cysteine Rich Domain (CRD). We show that HHIP-N is required to convey full HHIP inhibitory function, likely by interacting with the cholesterol moiety covalently linked to HH ligands, thereby preventing this SHH-attached cholesterol from binding to the HH receptor Patched (PTCH1). We also present the structure of the HHIP C-terminal domain in complex with the GAG heparin. Heparin can bind to both HHIP-N and HHIP-C, thereby inducing clustering at the cell surface and generating a high-avidity platform for SHH sequestration and inhibition. Our data suggest a multimodal mechanism, in which HHIP can bind two specific sites on the SHH morphogen, alongside multiple GAG interactions, to inhibit SHH signalling.

Hedgehog-Interacting Protein (HHIP) is the only reported secreted inhibitor of Sonic Hedgehog (SHH) signalling. Here, the authors report structures of the HHIP N- and C-terminal domains, both in complexes with glycosaminoglycans, providing insights into the molecular basis for SHH sequestration and inhibition.

Details

Title
Hedgehog-Interacting Protein is a multimodal antagonist of Hedgehog signalling
Author
Griffiths, Samuel C 1   VIAFID ORCID Logo  ; Schwab, Rebekka A 2 ; El Omari Kamel 3   VIAFID ORCID Logo  ; Bishop, Benjamin 2 ; Iverson, Ellen J 4 ; Malinauskas Tomas 2   VIAFID ORCID Logo  ; Dubey Ramin 4 ; Qian Mingxing 5 ; Covey, Douglas F 5 ; Gilbert, Robert J, C 2   VIAFID ORCID Logo  ; Rohatgi Rajat 4   VIAFID ORCID Logo  ; Siebold, Christian 2   VIAFID ORCID Logo 

 University of Oxford, Division of Structural Biology, Wellcome Centre for Human Genetics, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); Evotec (UK) Ltd., Milton Park, Abingdon, UK (GRID:grid.448222.a) (ISNI:0000 0004 0603 4164) 
 University of Oxford, Division of Structural Biology, Wellcome Centre for Human Genetics, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
 Science Division, Diamond Light Source, Harwell Science and Innovation Campus, Didcot, UK (GRID:grid.18785.33) (ISNI:0000 0004 1764 0696) 
 Stanford University School of Medicine, Departments of Biochemistry and Medicine, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956) 
 Washington University School of Medicine, Department of Developmental Biology, St. Louis, USA (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2608263026
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.